MB-104 is a CS1/SLAMF7 targeted CAR T Cell therapy being developed for multiple myeloma.
| SparkCures ID | 334 |
|---|---|
| Generic Name | MB-104 |
| Treatment Classifications | |
| Treatment Targets |
View all active clinical trials around the US.
The following is a listing of clinical trials for patients with multiple myeloma who have received three or more prior lines of therapy.
There are no resources, links or videos to display for this treatment.